Snowball logo
logo
ALLO_logo

Allogene Therapeutics, Inc

ALLO β€’ NASDAQ
$1.90-$0.04Β  (2.06%)

Frequently asked questions

What sector does Allogene Therapeutics, Inc (ALLO) operate in?

Allogene Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Allogene Therapeutics, Inc (ALLO) current stock price?

As of the latest data, Allogene Therapeutics, Inc stock price is $1.90, with a previous close of $1.94. Allogene Therapeutics, Inc lost -$0.04 in the last trading session, representing a -2.06% loss.

What is Allogene Therapeutics, Inc (ALLO) current market capitalization?

Allogene Therapeutics, Inc market cap is approximately 655.55 million.

What is Allogene Therapeutics, Inc (ALLO) Earnings Per Share (EPS)?

The trailing EPS is -$0.87, and the forward EPS is -$0.70.

What is Allogene Therapeutics, Inc (ALLO) EBITDA?

Allogene Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -39.35 million.

Does Allogene Therapeutics, Inc (ALLO) pay dividends?

No. Allogene Therapeutics, Inc does not pay a dividend.

What is Allogene Therapeutics, Inc (ALLO) beta (volatility) score?

Allogene Therapeutics, Inc has a beta of 0.460, indicating lower volatility than the overall market.